1. Home
  2. ONMD vs BHST Comparison

ONMD vs BHST Comparison

Compare ONMD & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneMedNet Corp

ONMD

OneMedNet Corp

N/A

Current Price

$5.36

Market Cap

31.3M

Sector

N/A

ML Signal

N/A

Logo BioHarvest Sciences Inc.

BHST

BioHarvest Sciences Inc.

N/A

Current Price

$1.75

Market Cap

33.1M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ONMD
BHST
Founded
2006
2007
Country
United States
Canada
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
31.3M
33.1M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
ONMD
BHST
Price
$5.36
$1.75
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $10.50
AVG Volume (30 Days)
★ 25.8K
23.7K
Earning Date
11-24-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 83.33
N/A
EPS
N/A
★ N/A
Revenue
★ $1,359,000.00
N/A
Revenue This Year
N/A
$8.44
Revenue Next Year
N/A
$32.53
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 111.35
N/A
52 Week Low
$0.63
$1.37
52 Week High
$115.00
$7.76

Technical Indicators

Market Signals
Indicator
ONMD
BHST
Relative Strength Index (RSI) 41.05 55.57
Support Level $3.86 $1.40
Resistance Level $39.25 $1.77
Average True Range (ATR) 0.52 0.13
MACD 0.75 0.02
Stochastic Oscillator 59.81 53.85

Price Performance

Historical Comparison
ONMD
BHST

About ONMD OneMedNet Corp

OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. Its technology has provens the commercial and regulatory viability of imaging Real World Data, an emerging market, and provides regulatory-grade, image-centric iRWDTM. Geographically, it operates in Americas, Europe and Middle East, and Asia Pacific. It derives maximum revenue from Europe and Middle East.

About BHST BioHarvest Sciences Inc.

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. The Company has two operating segments or business units: the Products business unit and the CDMO Services business unit. In identifying these operating segments, management generally follows the Company's service lines representing its main products and services. The Products Business Unit - Nutraceuticals: Research, development, manufacturing, marketing and sales of science-based health and wellness nutraceutical solutions which are manufactured and sold as dietary supplements, functional food and beverages. The CDMO Services Business Unit - comprising a Contract Development and Manufacturing Operation that offers pharmaceuticals, cosmeceuticals, nutraceuticals, and nutritions.

Share on Social Networks: